In our last blog, the HTA outlined how we and our stakeholders have a clear role to play in achieving the governments’ Life Sciences Vision, together delivering a progressive UK regulatory offer that unlocks innovation while safeguarding patients and ensuring public confidence. To do this, we need to constructively challenge our regulatory model and tools, looking at how we&nbs
Today the Human Tissue Authority (HTA) has published licence fee levels for the 2022/23 business year.
Having held license fees at 2020/21 levels for the current business year the HTA Board have approved an increase of 2% on the current fee levels. This increase will take effect from 1 April 2022 on the previous year’s fees. Read the full sector breakdowns.
All establishments licensed to carry out activities under the Human Tissue (Quality and Safety for Human Application) Regulations 2007 must submit data relating to the activities undertaken and the tissue types worked with between 1 January and 31 December on an annual basis.
Submission of the data is a condition of your HTA licence.
